ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

NCI, CDC To Collaborate On Surveillance System.

March 24, 2000

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977